Octagon Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Octagon Therapeutics's estimated annual revenue is currently $1.9M per year.
- Octagon Therapeutics's estimated revenue per employee is $143,077
Employee Data
- Octagon Therapeutics has 13 Employees.
- Octagon Therapeutics grew their employee count by 30% last year.
Octagon Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | VP Biology | Reveal Email/Phone |
2 | Lab Manager | Reveal Email/Phone |
3 | Interim CSO | Reveal Email/Phone |
4 | Research Associate | Reveal Email/Phone |
Octagon Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $10.1M | 48 | -9% | N/A | N/A |
#10 | $16.1M | 88 | 4% | N/A | N/A |
What Is Octagon Therapeutics?
Discovering new medicines based on metabolic vulnerabilities in pathological cell populations. Underlying platform uses engineered growth conditions to highlight novel metabolic targets in disease-causing bacteria, lymphocytes, and metastasizing cancer cells. Lead programs in autoimmunity and infectious disease.
keywords:N/A
N/A
Total Funding
13
Number of Employees
$1.9M
Revenue (est)
30%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.5M | 13 | -24% | N/A |
#2 | $5.2M | 13 | -70% | N/A |
#3 | $1.7M | 13 | -38% | N/A |
#4 | $1.7M | 13 | 0% | N/A |
#5 | $1.4M | 13 | N/A | N/A |